Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Marinus Pharma Halts Development After Seizure Drug Fails Trial

MD Bureau25 Oct 2024 3:13 PM IST

Marinus said it will discontinue development of the drug, ganaxolone, and take further steps to reduce costs, including job cuts.

Strides Pharma Posts Record Q2 Growth with Rs 12,011 Million Revenue, Highest Ever US Sales

MD Bureau25 Oct 2024 3:03 PM IST

Bengaluru: Strides Pharma Science Ltd. reported robust Q2FY25 financial results, ending September 30, 2024, with consolidated revenues at Rs 12,011...

'Insulin Tablets' banned, License of pharma firm cancelled after activist flags mislabeling risks for diabetics

Farhat Nasim25 Oct 2024 1:31 PM IST

New Delhi: The license of Bhargava Phytolabs, a Rajasthan-based pharmaceutical company, has been cancelled for manufacturing "Insulin Tablets," a...

Only D.Pharm, B.Pharm, M.Pharm, Pharm.D Holders Can Be Drug Wholesalers: DTAB

Farhat Nasim24 Oct 2024 6:02 PM IST

New Delhi: The Drugs Technical Advisory Board (DTAB) has reaffirmed its recommendation to finalize amendment to Rule 64 of the Drugs Rules, 1945,...

Even Healthcare raises Rs 252 crore in Series A funding to launch hospital operations, enhance patient care

MD Bureau24 Oct 2024 5:32 PM IST

Bengaluru: Even Healthcare, a Bengaluru-based managed care provider, recently secured USD 30 million (approximately Rs 252 crore) in a Series A...

Piramal Pharma Reports Over Fourfold Surge in Q2 Net Profit to Rs 23 Crore, Announces Expansion Plans

MD Bureau24 Oct 2024 4:35 PM IST

Revenue from operations rose to Rs 2,242 crore in the second quarter as compared with Rs 1,911 crore in the year-ago period, Piramal Pharma said.

delhi high court relief to mankind in infringement case against aquakind

Mankind Pharma Completes Rs 13,768 Crore Acquisition of Bharat Serums

MD Bureau24 Oct 2024 2:39 PM IST

Sanjiv Navangul, MD & CEO, BSV, said that being a part of the Mankind Pharma family makes BSV bigger, stronger and better.

Roche seeks to block Novo Nordisk's Catalent deal over weight-loss drug competition

MD Bureau24 Oct 2024 2:09 PM IST

"Limiting the competition in this space is not a good idea," Thomas Schinecker, CEO, Roche said.

David Joyner Takes Helm at CVS Amid Aetna Challenge

MD Bureau24 Oct 2024 9:45 AM IST

New York: As CVS Health's new CEO David Joyner steps into the top job after Karen Lynch's quick departure recently, Wall Street analysts and some...

Zydus Secures WHO Approval for Typhoid Vaccine ZyVac TCV, Eligible for UN Procurement

MD Bureau23 Oct 2024 6:46 PM IST

ZyVac TCV is indigenously developed and manufactured at the Zydus Biotech Park, Ahmedabad.

DoP rejects application challenging NPPA price fixation order on Metoprolol

Farhat Nasim23 Oct 2024 6:37 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has rejected a review application filed by Ajanta Pharma against price fixation order issued by...

Masina Hospital appoints Dr Akash Rajpal as Chief Operating Officer

MD Bureau23 Oct 2024 4:37 PM IST

Mumbai: Masina Hospital recently announced the appointment of Dr Akash Rajpal as its new Chief Operating Officer (COO).Bringing over 25 years of...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok